Abstract
External quality assessment schemes (EQAS) provide an important means of monitoring the quality of the performance of immunoassays in the field. Set up by external bodies and complementing internal quality control procedures, they enable ongoing comparison of individual laboratory results, both with independently established target values and with results of other participating laboratories. Well-designed EQAS assess analytical performance particularly with respect to bias and precision, but also give some indication of the type of errors that most frequently occur in routine practice.
EQAS must themselves meet nationally and/or internationally agreed standards so that participants can have confidence in the data generated. Some of the standards currently applied in the UK are described in this chapter, with examples of how these standards can be met also provided.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
World Health Organization (1981) External quality assessment of health laboratories (EURO reports & studies 6). World Health organization, Copenhagen
Seth J, Sturgeon CM, al-Sadie R et al (1991) External quality assessment of immunoassays of peptide hormones and tumour markers: principles and practice. Ann Ist Super Sanita 27:443–452
Miller WG, Jones GR, Horowitz GL et al (2011) Proficiency testing/external quality assessment: current challenges and future directions. Clin Chem 57:1670–1680
Burnett D (2002) A practical guide to accreditation in laboratory medicine. ACB Venture Publications, London
Clinical Pathology Accreditation (UK) Ltd. (2012) Standards for EQA schemes in laboratory medicine. CPA (UK) Ltd.: Feltham, Middlesex; 2010. http://www.cpa-uk.co.uk/. Accessed 3 Nov 2012
ISO. Conformity assessment (2010) General requirements for proficiency testing (ISO/CASCO 17043:2010)
Sturgeon CM, Ellis AR, Al Sadie R (2012) UK NEQAS [Edinburgh]. Annual review for 2012. Available from UK NEQAS [Edinburgh]
National Laboratory Medicine Catalogue (NLMC) (2012) http://www.connectingforhealth.nhs.uk/systemsandservices/pathology/projects/nlmc. Accessed 3 Nov 2012
Pathology harmony. http://www.pathologyharmony.co.uk/. Accessed July 2013
CLSI (1999) Preparation and validation of commutable frozen human serum pools as secondary reference materials for cholesterol measurement procedures; approved guideline. CLSI document 37-A. CLSI, Wayne, PA
White GH (2011) Metrological traceability in clinical biochemistry. Ann Clin Biochem 48:393–409
BIPM/JCTLM. http://www.bipm.org/. Accessed July 2013
Sturgeon CM, Berger P, Bidart JM et al (2009) Differences in recognition of the 1st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin. Clin Chem 55:1484–1491
Healy MJ (1979) Outliers in clinical chemistry quality-control schemes. Clin Chem 25:675–677
Stockley JM (2005) The UK national quality assurance advisory panel—taking an overview on quality. Clin Chim Acta 355:S447–S448
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this protocol
Cite this protocol
Sturgeon, C. (2013). External Quality Assessment Schemes for Immunoassays. In: Wheeler, M. (eds) Hormone Assays in Biological Fluids. Methods in Molecular Biology, vol 1065. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-616-0_19
Download citation
DOI: https://doi.org/10.1007/978-1-62703-616-0_19
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-615-3
Online ISBN: 978-1-62703-616-0
eBook Packages: Springer Protocols